Axway Partners with Navitas to Enable Digital Business for the Pharmaceutical Industry
Axway (Paris:AXW) (Euronext: AXW.PA), a market leader in digital business enablement, has announced a partnership with Navitas , a leading global business technology company with deep domain expertise in life sciences and supply chain management, to bring to market an integrated Axway Nativas Solution. The global traceability and compliance solution is designed to allow senior management and regulatory leaders at pharmaceutical companies to more readily embrace digital business workflows by facilitating compliance and eliminating the need to invest in costly and complex infrastructures.
Like most global industries, the pharmaceutical industry is looking to engage in digital initiatives to optimize operational efficiency, improve partner interactions, and keep the pace with rising consumer demands. Yet, such digital business mandates place immense pressure on pharmaceutical companies to move towards more agile supply chain ecosystems while ensuring their IT infrastructure addresses increasingly complex regulatory and compliance directives.
The Axway Navitas Solution, hosted by Navitas or deployed on premise, offers the industry’s only end-to-end traceability solution designed and implemented to meet clients’ unique requirements. Guided by industry best practices and powered by Axway Track & Trace , the solution allows pharmaceutical executives to increase visibility across global supply chain ecosystems. The single system approach integrates and streamlines multiple validation processes and workflows to reduce the cost and burden of regulatory compliance.
“Everything we do at Navitas is geared toward providing a great user experience to enable better outcomes and to make more informed decisions,” said David Gwyn, Technology Practice Leader at Navitas. “We have a strong expertise in Axway digital enablement solutions, and we are convinced that this combined infrastructure offering will be the most reliable, secure and cost-effective offering available for pharmaceutical and retail organizations to address tracking and compliance issues in a complex digital environment.”
By combining Navitas’ regulatory and healthcare operations expertise with Axway’s robust integration foundation and ecosystem engagement capabilities, the solution provides organizations visibility to the data they need to secure the integrity of their supply chain – resulting in improved quality and patient outcomes.
“We partnered with Navitas so we can further transform rigid supply chains into responsive and ultimately, more proactive end-to-end systems,” said Jeanine Banks, executive vice president, global products and solutions, Axway. “The ROI is even greater when you can leverage the cloud to transparently monitor a supply chain and ensure compliance while supporting vastly expanding partner ecosystems, particularly with pharmaceutical companies wanting to embrace digital business.”
Follow Axway on Twitter: @Axway #DigitalBusiness
Axway (Euronext: AXW.PA) empowers more than 11,000 customers worldwide to collaborate smarter, innovate faster and engage better with their partners, developers and customers. From integration technology that securely connects people, processes and things to an engagement platform that enables API management, identity management, mobile app development and analytics, Axway solutions are enabling digital business. Axway is registered in France with headquarters in the United States. More information is available at: www.axway.com .
The Navitas team has been assembled bringing together the proven expert teams of TAKE Life Sciences and WCI Consulting and, adding to this core, a range of experts from the worlds of Clinical Development, Regulatory, Technology, and Consulting.
We have built the Navitas team specifically to deliver insight to our clients, to develop pragmatic solutions together, and to support their deployment and operation. We deliver advice, solutions, and outsourcing services in Clinical, Regulatory, Safety, and Content Management.
We are proud that our legacy businesses have served the sector for some 15 years and have allowed us to work with 100 of the top Life Science companies. Our team has now grown to over 500 staff. For more information, visit www.navitas.net .
Blanc & Otus
Neil Desai, 415-856-5150
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FL-MLB22.9.2018 00:15 | pressemeddelelse
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)
NY-BCW/PALLADINO21.9.2018 19:45 | pressemeddelelse
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice
HEIDELBERG-ENGINEERING21.9.2018 18:43 | pressemeddelelse
Heidelberg Engineering Announces the CE-Marking of ANTERION
JEDOX21.9.2018 17:48 | pressemeddelelse
Florian Winterstein Becomes New CEO of Jedox
AVINOR21.9.2018 16:39 | pressemeddelelse
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter
MA-TAKEDA-PHARMACEUTICAL21.9.2018 15:32 | pressemeddelelse
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum